0
Cell & Gene Therapy Pipelines
0
Key Manufacturing Parameters
0
Key Pipeline Parameters
0
Key Companies Covered
Tracker Highlights
left
right

Competitive Assessment

This tracker provides an in-depth overview of the upcoming competition in the cell & gene therapy market of South-Asia & SEA countries. Through this tracker IMAPAC aims to assist organizations to keep track of their competitors, identify any opportunities for collaboration or investments for development or manufacturing of cell & gene therapies and support key strategic decisions making for the business.

Key Pipeline Parameters

More than 20 parameters such as company overview, current cell & gene therapy products in pipeline, product’s stage of development, product by therapy type, autologous or allogenic therapies, disease or indication, target for each product candidate, route of administration, and technology employed in product’s development.

Explore More, Request A Demoright
parameters

Key Manufacturing Parameters

22+ parameters including facility centers, facility size, facility investment, production capacity, types of products manufactured in the facility, key features of the facility, operation scale, process technology, regulatory approvals & certifications, expansion plans and other vital information.

Explore More, Request A Demoright

Key Companies Covered

Tessa Therapeutics, Carina Biotechnology, Lion TCR, Orthocell, Lonza AG, Singcell, Mesoblast, Intas Pharmaceutical, Cell Therapies and other top cell & gene therapy companies in the region.

Explore More, Request A Demoright
bag